Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
28.00
-0.44 (-1.55%)
At close: Jun 2, 2026
SHE:301166 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 339.51 | 545.52 | 840.16 | 414.53 | 732.14 | 1,873 |
Short-Term Investments | - | - | - | - | 50.76 | - |
Trading Asset Securities | 867.66 | 803.59 | 565.23 | 1,062 | 901.24 | - |
Cash & Short-Term Investments | 1,207 | 1,349 | 1,405 | 1,476 | 1,684 | 1,873 |
Cash Growth | -11.21% | -4.00% | -4.80% | -12.34% | -10.08% | 647.25% |
Accounts Receivable | 407.12 | 362.96 | 350.56 | 361.81 | 375.78 | 264.79 |
Other Receivables | 3.43 | 6.46 | 20.5 | 17.46 | 14.35 | 8.67 |
Receivables | 410.56 | 369.42 | 371.06 | 379.28 | 390.13 | 273.46 |
Inventory | 144.91 | 128.47 | 129.51 | 201.54 | 168.32 | 77.35 |
Other Current Assets | 40.82 | 22.17 | 31.17 | 32.35 | 66.11 | 31.69 |
Total Current Assets | 1,803 | 1,869 | 1,937 | 2,089 | 2,309 | 2,255 |
Property, Plant & Equipment | 259.68 | 258.5 | 225.47 | 194.83 | 102.43 | 34.91 |
Long-Term Investments | 113.12 | 75.54 | 54.81 | 31.66 | 27.5 | - |
Other Intangible Assets | 8.76 | 8.69 | 10.52 | 8.54 | 7.57 | 6.13 |
Long-Term Deferred Tax Assets | 95.7 | 87.99 | 76.3 | 59.14 | 33.71 | 15.17 |
Long-Term Deferred Charges | 2.05 | 2.48 | 4.96 | 7.7 | 4.34 | 1.4 |
Other Long-Term Assets | 0.43 | 0.04 | 0.22 | 0.09 | - | 0.09 |
Total Assets | 2,283 | 2,302 | 2,309 | 2,391 | 2,484 | 2,313 |
Accounts Payable | 73.48 | 96.43 | 95.39 | 110.58 | 76.04 | 83.54 |
Accrued Expenses | 22.11 | 37.51 | 32.6 | 43.01 | 34.88 | 38.88 |
Short-Term Debt | 69.47 | 44.47 | - | - | 80 | - |
Current Portion of Leases | 4.88 | 4.58 | 5.94 | - | - | - |
Current Income Taxes Payable | 8.53 | 1.12 | 6.61 | 7.43 | 10.08 | 10.47 |
Current Unearned Revenue | 85.5 | 87.67 | 69.44 | 74.32 | 80.72 | 69.24 |
Other Current Liabilities | 14.77 | 13.43 | 12.65 | 6.29 | 13.17 | 16.22 |
Total Current Liabilities | 278.74 | 285.21 | 222.63 | 241.63 | 294.9 | 218.35 |
Long-Term Leases | 4 | 4.59 | 11.38 | 23.46 | 23.19 | 4.58 |
Long-Term Unearned Revenue | 4.46 | 4.2 | 3.59 | - | 0.01 | 0.02 |
Long-Term Deferred Tax Liabilities | 2.78 | 2.56 | 3.92 | 6.18 | 6.07 | - |
Other Long-Term Liabilities | - | - | - | 2.96 | 2.62 | 1.84 |
Total Liabilities | 289.98 | 296.56 | 241.52 | 274.23 | 326.77 | 224.8 |
Common Stock | 86.67 | 86.67 | 86.67 | 86.67 | 86.67 | 86.67 |
Additional Paid-In Capital | 1,715 | 1,715 | 1,715 | 1,715 | 1,719 | 1,715 |
Retained Earnings | 231.44 | 239.93 | 282.6 | 313.17 | 350.85 | 287.73 |
Treasury Stock | -41 | -37.76 | -19.5 | - | - | - |
Comprehensive Income & Other | 0.89 | 1.81 | 2.92 | 2.09 | 1.37 | -1.36 |
Shareholders' Equity | 1,993 | 2,006 | 2,068 | 2,117 | 2,157 | 2,088 |
Total Liabilities & Equity | 2,283 | 2,302 | 2,309 | 2,391 | 2,484 | 2,313 |
Total Debt | 78.35 | 53.65 | 17.32 | 23.46 | 103.19 | 4.58 |
Net Cash (Debt) | 1,129 | 1,295 | 1,388 | 1,453 | 1,581 | 1,868 |
Net Cash Growth | -15.94% | -6.67% | -4.46% | -8.11% | -15.38% | 676.40% |
Net Cash Per Share | 12.93 | 14.68 | 16.41 | 16.94 | 18.24 | 28.52 |
Filing Date Shares Outstanding | 84.96 | 85.24 | 85.74 | 86.63 | 86.67 | 86.67 |
Total Common Shares Outstanding | 84.96 | 85.24 | 85.98 | 86.67 | 86.67 | 86.67 |
Working Capital | 1,525 | 1,584 | 1,715 | 1,848 | 2,014 | 2,037 |
Book Value Per Share | 23.46 | 23.53 | 24.05 | 24.43 | 24.89 | 24.10 |
Tangible Book Value | 1,984 | 1,997 | 2,057 | 2,109 | 2,150 | 2,082 |
Tangible Book Value Per Share | 23.36 | 23.43 | 23.93 | 24.33 | 24.81 | 24.02 |
Buildings | - | 232.35 | 183.97 | 34.36 | 34.36 | - |
Machinery | - | 85.52 | 75.52 | 59.39 | 36.54 | 20.23 |
Construction In Progress | - | 0.81 | 2.19 | 118.43 | 39.39 | 2.21 |